dronabinol has been researched along with Depression in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (23.26) | 18.7374 |
1990's | 1 (2.33) | 18.2507 |
2000's | 8 (18.60) | 29.6817 |
2010's | 21 (48.84) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Baker, NL; Gilmore, AK; Gray, KM; Hood, CO; McClure, EA; McRae-Clark, AL; Sonne, SC; Squeglia, LM; Tomko, RL | 1 |
Davis, N; Gorelick, J; Kardash, T; Kirby, M; Koman, I; Michaelevski, I; Pinhasov, A; Rodin, D | 1 |
Mason, MJ | 1 |
Stavreva, GT; Tashev, RE; Velikova, MS | 1 |
Carmona, NE; Cha, DS; Ho, RC; Lee, Y; Mansur, RB; McIntyre, RS; Ragguett, RM; Rong, C; Rosenblat, JD | 1 |
Bader, M; Cohen, E; Gabet, Y; Katz, Y; Lenchinski, T; Meningher, I; Pick, CG; Rotenberg, M; Rubovitch, V; Schreiber, S; Wolf, EU | 1 |
Cuttler, C; McLaughlin, RJ; Spradlin, A | 1 |
Cuccurazzu, B; Grilli, M; Nazzaro, C; Parolaro, D; Prini, P; Rubino, T; Tonini, R; Trusel, M; Zamberletti, E | 1 |
Bar-Hamburger, R; Bloch, M; Bluvstein, I; Miller, H; Rapoport, E; Schreiber, S; Weinstein, AM | 1 |
Atkinson, JH; Gouaux, B; Marcotte, TD; Umlauf, A; Wallace, MS | 1 |
Leitl, MD; Negus, SS | 1 |
Bayman, L; Hashmi, S; Malik, Z; Rizvi-Toner, A; Schey, R; Valestin, J | 1 |
Fernández, Ó | 1 |
Bloomfield, MA; Curran, HV; Das, RK; Freeman, TP; Harvey, L; Hindocha, C; Joye, A; Lawn, W; Mokrysz, C; Morgan, CJ; Moss, A; Nutt, DJ; Pope, RA; Wall, MB | 1 |
Ciccone, CD | 1 |
Abdel-Salam, OME; Hosny, EN; Khadrawy, YA; Sawie, HG | 1 |
Costentin, J | 1 |
Díaz, A; Pazos, A; Rodríguez-Gaztelumendi, A; Rojo, ML | 1 |
Alberio, T; Braida, D; Capurro, V; Fasano, M; Guidali, C; Parolaro, D; Realini, N; Rubino, T; Sala, M; Viganò, D | 1 |
Hughes, JR; Peters, EN | 1 |
Emery, CJ; Gandhi, R; Selvarajah, D; Tesfaye, S | 1 |
Ahmed, S; El-Alfy, AT; ElSohly, M; Ivey, K; Khan, I; Radwan, M; Robinson, K; Ross, S; Slade, D | 1 |
Goldman, B; Truniger, S; Weber, M | 1 |
Curran, HV; Demarchi, C; Freeman, TP; Gardener, C; Lewis, S; Morgan, CJ; Ramoutar, A; Rupasinghe, I; Schafer, G; Swan, S; Tan, N; Warrington, P; Wingham, G | 1 |
Ashton, CH; Moore, PB | 1 |
Elbatsh, MM; Kendall, DA; Marsden, CA; Moklas, MA | 1 |
Cachope, R | 1 |
Atlani, S; Attal, N; Brasseur, L; Clermont-Gnamien, S; Guirimand, F; Le Mercier, F | 1 |
Bechara, A; Lamers, CT; Ramaekers, JG; Rizzo, M | 1 |
Gorzalka, BB; Hill, MN; McLaughlin, RJ; Morrish, AC | 1 |
Bernstein, A; Bonn-Miller, MO; Stickle, TR; Zvolensky, MJ | 1 |
Lutz, B; Moreira, FA | 1 |
Volicer, L | 1 |
Abrams, AA; Clopton, PL; Janowsky, DS; Judd, LL; Leichner, PP; Pechnick, R | 1 |
Bhargava, HN | 1 |
Cohen, S | 1 |
Tunving, K | 1 |
Dittrich, A; Woggon, B | 2 |
Goodwin, FK; Kotin, J; Post, RM | 1 |
Ablon, SL; Goodwin, FK | 1 |
Fairbairn, JW; Hindmarch, I; Simic, S; Tylden, E | 1 |
Brown, DJ; Forney, RB; Hubbard, JD; Martz, R; Phillips, RN | 1 |
9 review(s) available for dronabinol and Depression
Article | Year |
---|---|
Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Topics: Affect; Anxiety; Brain; Cannabidiol; Cognition; Depression; Dronabinol; Humans; Medical Marijuana; Sleep; Sleep Initiation and Maintenance Disorders | 2017 |
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
Topics: Accidental Falls; Cannabidiol; Depression; Dronabinol; Drug Combinations; Germany; Humans; Marijuana Abuse; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Plant Extracts; Prospective Studies; Registries; Retrospective Studies; Spain; Switzerland; Treatment Outcome; United Kingdom | 2016 |
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
Topics: Cannabidiol; Cognition Disorders; Confusion; Controlled Substances; Depression; Dronabinol; Drug Administration Routes; Hallucinations; Heart; Humans; Lung; Marijuana Abuse; Medical Marijuana; Memory Disorders; Muscle Spasticity; Nausea; Pain; Physical Therapists; Postural Balance; Professional Role; Vomiting | 2017 |
[Neuropsychopharmacology of delta-9-tetrahydrocannabinol].
Topics: Anxiety; Cannabinoid Receptor Modulators; Cognition; Depression; Dronabinol; Humans; Marijuana Abuse; Marijuana Smoking; Nervous System; Psychoses, Substance-Induced; Psychotropic Drugs; Receptor, Cannabinoid, CB1; Schizophrenic Psychology | 2008 |
Endocannabinoid system dysfunction in mood and related disorders.
Topics: Anxiety; Bipolar Disorder; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Cerebral Cortex; Depression; Dronabinol; Electroencephalography; Endocannabinoids; Humans; Mood Disorders; Pain; Receptors, Cannabinoid; Schizophrenia; Suicide | 2011 |
Functional diversity on synaptic plasticity mediated by endocannabinoids.
Topics: Animals; Brain; Depression; Dronabinol; Endocannabinoids; Humans; Ligands; Mental Disorders; Neuronal Plasticity; Presynaptic Terminals; Receptor, Cannabinoid, CB1; Synaptic Transmission; Time Factors; TRPV Cation Channels | 2012 |
The endocannabinoid system: emotion, learning and addiction.
Topics: Animals; Anxiety; Arousal; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Depression; Dose-Response Relationship, Drug; Dronabinol; Emotions; Endocannabinoids; Fear; Humans; Learning; Marijuana Abuse; Mice; Neurotransmitter Agents; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome; Substance-Related Disorders | 2008 |
Tube feeding in Alzheimer's disease is avoidable.
Topics: Alzheimer Disease; Antidepressive Agents; Contraindications; Depression; Dronabinol; Eating; Enteral Nutrition; Humans; Psychotropic Drugs; Sertraline; Weight Loss | 1998 |
Psychiatric effects of cannabis use.
Topics: Acute Disease; Adolescent; Adolescent Behavior; Adult; Anxiety; Cerebrovascular Circulation; Chronic Disease; Cognition; Depression; Dronabinol; Electroencephalography; Female; Humans; Male; Marijuana Abuse; Mental Disorders; Middle Aged; Motivation; Personality Disorders; Psychoses, Substance-Induced; Substance Withdrawal Syndrome | 1985 |
14 trial(s) available for dronabinol and Depression
Article | Year |
---|---|
Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
Topics: Acetylcysteine; Adult; Cannabis; Comorbidity; Depression; Double-Blind Method; Dronabinol; Female; Free Radical Scavengers; Humans; Male; Marijuana Abuse; Motivation; Treatment Outcome; Young Adult | 2020 |
Depressive symptoms moderate cannabis use for young adults in a Text-Delivered randomized clinical trial for cannabis use disorder.
Topics: Adolescent; Adult; Depression; Dronabinol; Female; Humans; Male; Marijuana Abuse; Patient Health Questionnaire; Self Report; Telemedicine; Text Messaging; Treatment Outcome; Young Adult | 2020 |
Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study.
Topics: Adult; Anxiety; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Young Adult | 2014 |
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.
Topics: Administration, Inhalation; Aged; Analgesics, Non-Narcotic; Analysis of Variance; Cognition; Cross-Over Studies; Depression; Diabetic Neuropathies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Pain Measurement; Time Factors; Treatment Outcome | 2015 |
Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial.
Topics: Adult; Cannabinoid Receptor Agonists; Chest Pain; Deglutition Disorders; Depression; Double-Blind Method; Dronabinol; Esophagus; Female; Humans; Hypersensitivity; Male; Middle Aged; Pain Threshold; Pilot Projects; Prospective Studies; Surveys and Questionnaires; Treatment Outcome | 2017 |
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
Topics: Administration, Inhalation; Adult; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Choice Behavior; Decision Making; Depression; Double-Blind Method; Dronabinol; Female; Humans; Learning; Male; Marijuana Abuse; Marijuana Smoking; Motivation; Reward; Young Adult | 2016 |
Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor.
Topics: Adult; Aged; Cannabidiol; Depression; Diabetic Neuropathies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Placebos; Plant Extracts; Quality of Life; Treatment Outcome | 2010 |
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Appetite; Cross-Over Studies; Depression; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Muscle Cramp; Quality of Life; Severity of Illness Index; Sleep Wake Disorders | 2010 |
Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Cognition Disorders; Decision Making; Depression; Discrimination Learning; Dronabinol; Drug Synergism; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Problem Solving; Reaction Time; Serotonin Agents; Set, Psychology | 2006 |
Interpersonal effects of marijuana. A model for the study of interpersonal psychopharmacology.
Topics: Adult; Affect; Anxiety; Cannabis; Depression; Dronabinol; Empathy; Female; Hostility; Humans; Interpersonal Relations; Male; Research Design; Social Behavior | 1979 |
Subjective syndromes, physiological changes and after-effects of the acute 9-tetrahydrocannabinol intoxication. Two double-blind studies in volunteers.
Topics: Acute Disease; Anxiety; Blood Pressure; Body Temperature; Cannabis; Clinical Trials as Topic; Depersonalization; Depression; Dronabinol; Euphoria; Factor Analysis, Statistical; Humans; Hydrogen-Ion Concentration; Hypertension; Pulse; Saliva | 1972 |
9 -Tetrahydrocannabinol in depressed patients.
Topics: Administration, Oral; Adult; Affect; Affective Symptoms; Anxiety; Body Image; Cannabis; Clinical Trials as Topic; Depersonalization; Depression; Dronabinol; Female; Humans; Informed Consent; Male; Middle Aged; Phytotherapy; Placebos; Pulse; Self Concept; Sleep | 1973 |
High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients.
Topics: Adult; Anger; Antidepressive Agents; Anxiety; Cannabis; Clinical Trials as Topic; Depression; Dronabinol; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; Psychotic Disorders | 1974 |
[Subjective changes with delta 9 trans-tetrahydrocannabinol in cannabis naive subjects].
Topics: Administration, Oral; Adult; Anxiety; Attention; Behavior; Blood Pressure; Body Temperature; Cannabis; Clinical Trials as Topic; Depersonalization; Depression; Dose-Response Relationship, Drug; Dronabinol; Euphoria; Female; Hallucinations; Humans; Hydrogen-Ion Concentration; Male; Memory; Placebos; Pulse; Time Factors | 1974 |
20 other study(ies) available for dronabinol and Depression
Article | Year |
---|---|
Link between personality and response to THC exposure.
Topics: Animals; Behavior, Animal; Cannabinoid Receptor Agonists; Conditioning, Psychological; Corticosterone; Depression; Disease Models, Animal; Dominance-Subordination; Dronabinol; Male; Mice; Personality | 2020 |
Subchronic Central Administration of Cannabinoid Ligands Modulates Nociception in Bulbectomized Rats.
Topics: Animals; Depression; Disease Models, Animal; Dronabinol; Ligands; Male; Nociception; Olfactory Bulb; Pain Threshold; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2019 |
Functional effects of synthetic cannabinoids versus Δ
Topics: Animals; Anxiety; Body Temperature; Depression; Dronabinol; Indazoles; Male; Maze Learning; Memory; Mice, Inbred ICR; Motor Activity; Nociception; Psychotropic Drugs; Sensory Thresholds; Valine | 2019 |
A naturalistic examination of the perceived effects of cannabis on negative affect.
Topics: Adult; Affect; Anxiety; Cannabidiol; Depression; Dose-Response Relationship, Drug; Dronabinol; Female; Humans; Male; Perception; Stress, Psychological | 2018 |
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling.
Topics: Adaptation, Psychological; Animals; Arachidonic Acids; Benzamides; Carbamates; Dentate Gyrus; Depression; Dronabinol; Endocannabinoids; Female; Marijuana Abuse; Neurogenesis; Neuronal Plasticity; Polyunsaturated Alkamides; Prefrontal Cortex; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Sexual Maturation; Signal Transduction; Synapses; Tissue Culture Techniques | 2018 |
Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.
Topics: Analgesics; Analgesics, Opioid; Animals; Bupropion; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Electric Stimulation; Formaldehyde; Hyperalgesia; Ketoprofen; Male; Medial Forebrain Bundle; Morphine; Neuralgia; Rats; Rats, Sprague-Dawley; Self Stimulation | 2016 |
Cannabis exacerbates depressive symptoms in rat model induced by reserpine.
Topics: Acetylcholinesterase; Animals; Cannabis; Cerebral Cortex; Depression; Disease Models, Animal; Dopamine; Dronabinol; Hippocampus; Male; Motor Activity; Norepinephrine; Oxidative Stress; Rats, Wistar; Reserpine; Serotonin; Sodium-Potassium-Exchanging ATPase | 2017 |
Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Autoradiography; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Exploratory Behavior; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Immunosuppressive Agents; Isotopes; Male; Olfactory Bulb; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Signal Transduction; Time Factors | 2009 |
The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex.
Topics: Analysis of Variance; Animals; Animals, Newborn; Area Under Curve; Avoidance Learning; Cognition Disorders; Depression; Disease Models, Animal; Disks Large Homolog 4 Protein; Dronabinol; Female; Glial Fibrillary Acidic Protein; Intracellular Signaling Peptides and Proteins; Maze Learning; Membrane Proteins; Neuronal Plasticity; Prefrontal Cortex; Proteomics; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Reaction Time; Synaptophysin; Tubulin | 2009 |
Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence.
Topics: Adolescent; Adult; Aggression; Alcohol Drinking; Alcoholism; Anger; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dronabinol; Educational Status; Employment; Feeding and Eating Disorders; Female; Humans; Male; Marijuana Abuse; Marital Status; Patient Selection; Sleep Wake Disorders; Substance Withdrawal Syndrome | 2010 |
Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
Topics: Animals; Antidepressive Agents; Cannabidiol; Cannabinoids; Cannabis; Catalepsy; Depression; Dose-Response Relationship, Drug; Dronabinol; Hindlimb Suspension; Hypothermia; Immobility Response, Tonic; Male; Mice; Random Allocation; Swimming | 2010 |
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
Topics: Adolescent; Adult; Anxiety; Cannabidiol; Cognition Disorders; Depression; Dronabinol; Female; Hair; Humans; Illicit Drugs; Male; Marijuana Smoking; Memory; Psychoses, Substance-Induced; Schizotypal Personality Disorder; Young Adult | 2012 |
Antidepressant-like effects of Δ⁹-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cannabinoid Receptor Antagonists; Depression; Disease Models, Animal; Dronabinol; Frontal Lobe; Hippocampus; Male; MAP Kinase Signaling System; Olfactory Bulb; Piperidines; Pyrazoles; Rats; Rimonabant | 2012 |
[The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain].
Topics: Aged; Analgesics; Analgesics, Non-Narcotic; Anxiety; Data Interpretation, Statistical; Depression; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neuralgia; Pain; Pain Measurement; Pilot Projects; Polyneuropathies; Quality of Life; Surveys and Questionnaires | 2002 |
Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Dentate Gyrus; Depression; Disease Models, Animal; Dronabinol; Hippocampus; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Stress, Psychological; Swimming | 2007 |
Marijuana coping motives interact with marijuana use frequency to predict anxious arousal, panic related catastrophic thinking, and worry among current marijuana users.
Topics: Adaptation, Psychological; Adolescent; Adult; Alcohol Drinking; Anxiety; Arousal; Comorbidity; Cross-Sectional Studies; Culture; Depression; Dronabinol; Female; Humans; Male; Marijuana Abuse; Motivation; Panic; Personality Inventory; Self Medication; Smoking; Thinking; Young Adult | 2008 |
Potential therapeutic applications of naturally occurring and synthetic cannabinoids.
Topics: Alcoholism; Animals; Appetite; Asthma; Cannabinoids; Cough; Depression; Diarrhea; Dronabinol; Epilepsy; Glaucoma; Humans; Hypertension; Narcotics; Neoplasms; Pain; Parasympatholytics; Substance-Related Disorders; Vomiting | 1978 |
Marijuana. Does it have a possible therapeutic use?
Topics: Asthma; Cannabinoids; Cannabis; Depression; Dronabinol; Drug Stability; Epilepsy; Glaucoma; Humans; Pain; Vomiting | 1978 |
Cannabinoid content of some English reefers.
Topics: Cannabis; Depersonalization; Depression; Dose-Response Relationship, Drug; Dronabinol; England; Humans; Paranoid Disorders; Psychoses, Substance-Induced; Remission, Spontaneous; Substance-Related Disorders | 1974 |
Subacute toxicity of aqueous-suspended 9 -tetrahydrocannabinol in rats.
Topics: Animals; Ataxia; Behavior, Animal; Body Weight; Cannabis; Depression; Diarrhea; Dronabinol; Humans; Injections, Intraperitoneal; Lacrimal Apparatus; Liver; Lung; Male; Organ Size; Rats; Rats, Inbred Strains; Time Factors | 1972 |